Akebia Therapeutics Statistics
Total Valuation
AKBA has a market cap or net worth of $332.26 million. The enterprise value is $399.48 million.
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024, before market open.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AKBA has 210.29 million shares outstanding. The number of shares has increased by 7.22% in one year.
Shares Outstanding | 210.29M |
Shares Change (YoY) | +7.22% |
Shares Change (QoQ) | +2.32% |
Owned by Insiders (%) | 2.74% |
Owned by Institutions (%) | 25.79% |
Float | 190.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.81 |
Forward PS | 1.78 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.29 |
EV / EBITDA | 97.89 |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04
Current Ratio | 1.04 |
Quick Ratio | 0.65 |
Debt / Equity | n/a |
Debt / EBITDA | 10.38 |
Debt / FCF | n/a |
Interest Coverage | -4.48 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -8.84% |
Return on Capital (ROIC) | -26.29% |
Revenue Per Employee | $1.04M |
Profits Per Employee | -$242,168 |
Employee Count | 167 |
Asset Turnover | 0.74 |
Inventory Turnover | 1.38 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.35% in the last 52 weeks. The beta is 0.76, so AKBA's price volatility has been lower than the market average.
Beta (5Y) | 0.76 |
52-Week Price Change | +89.35% |
50-Day Moving Average | 1.40 |
200-Day Moving Average | 1.38 |
Relative Strength Index (RSI) | 70.18 |
Average Volume (20 Days) | 1,475,136 |
Short Selling Information
The latest short interest is 18.80 million, so 8.94% of the outstanding shares have been sold short.
Short Interest | 18.80M |
Short Previous Month | 19.06M |
Short % of Shares Out | 8.94% |
Short % of Float | 9.88% |
Short Ratio (days to cover) | 12.81 |
Income Statement
In the last 12 months, AKBA had revenue of $174.50 million and -$40.44 million in losses. Loss per share was -$0.21.
Revenue | 174.50M |
Gross Profit | 143.60M |
Operating Income | -33.52M |
Pretax Income | -40.44M |
Net Income | -40.44M |
EBITDA | 4.08M |
EBIT | -33.52M |
Loss Per Share | -$0.21 |
Full Income Statement Balance Sheet
The company has $39.50 million in cash and $104.62 million in debt, giving a net cash position of -$65.12 million or -$0.31 per share.
Cash & Cash Equivalents | 39.50M |
Total Debt | 104.62M |
Net Cash | -65.12M |
Net Cash Per Share | -$0.31 |
Equity (Book Value) | -33.75M |
Book Value Per Share | -0.16 |
Working Capital | 4.80M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$38.97 million and capital expenditures -$29,000, giving a free cash flow of -$39.00 million.
Operating Cash Flow | -38.97M |
Capital Expenditures | -29,000 |
Free Cash Flow | -39.00M |
FCF Per Share | -$0.19 |
Full Cash Flow Statement Margins
Gross margin is 82.29%, with operating and profit margins of -19.21% and -23.18%.
Gross Margin | 82.29% |
Operating Margin | -19.21% |
Pretax Margin | -23.18% |
Profit Margin | -23.18% |
EBITDA Margin | 2.34% |
EBIT Margin | -19.21% |
FCF Margin | -22.35% |
Dividends & Yields
AKBA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.22% |
Shareholder Yield | -7.22% |
Earnings Yield | -12.10% |
FCF Yield | -11.66% |
Analyst Forecast
The average price target for AKBA is $5.75, which is 263.92% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.75 |
Price Target Difference | 263.92% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 18.40% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AKBA has an Altman Z-Score of -9.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -9.49 |
Piotroski F-Score | 2 |